PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
0.34 - 0.34
0.23 - 0.41
110.0K / 51.2K (Avg.)
-1.33 | -0.26
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
139.63%
Revenue growth above 1.5x PONY's 53.48%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
-6.61%
Negative gross profit growth while PONY is at 49.53%. Joel Greenblatt would examine cost competitiveness or demand decline.
No Data
No Data available this quarter, please select a different quarter.
27.23%
Positive operating income growth while PONY is negative. John Neff might view this as a competitive edge in operations.
33.87%
Positive net income growth while PONY is negative. John Neff might see a big relative performance advantage.
31.25%
Positive EPS growth while PONY is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
31.25%
Positive diluted EPS growth while PONY is negative. John Neff might view this as a strong relative advantage in controlling dilution.
0.00%
Share reduction more than 1.5x PONY's 4.32%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-121.39%
Negative OCF growth while PONY is at 0.00%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-116.54%
Negative FCF growth while PONY is at 0.00%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
-87.78%
Both companies have negative long-term revenue/share growth. Martin Whitman would question if the entire market or product set is shrinking.
-88.16%
Both face negative 5Y revenue/share CAGR. Martin Whitman would suspect macro headwinds or obsolete product offerings across the niche.
-60.23%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
13.79%
OCF/share CAGR of 13.79% while PONY is zero. Bruce Berkowitz might see a slight advantage that could compound over time.
38.22%
OCF/share CAGR of 38.22% while PONY is zero. Bruce Berkowitz would see if modest momentum can translate into a bigger competitive lead.
-49.02%
Negative 3Y OCF/share CAGR while PONY stands at 0.00%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
-264.27%
Negative 10Y net income/share CAGR while PONY is at 63.21%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-5490.50%
Negative 5Y net income/share CAGR while PONY is 63.21%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-473.19%
Negative 3Y CAGR while PONY is 63.21%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
-7.01%
Negative equity/share CAGR over 10 years while PONY stands at 132.50%. Joel Greenblatt sees a fundamental red flag unless the competitor also struggles.
-24.07%
Negative 5Y equity/share growth while PONY is at 132.50%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
-19.64%
Negative 3Y equity/share growth while PONY is at 132.50%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
-100.00%
Cut dividends over 10 years while PONY stands at 0.00%. Joel Greenblatt suspects a weaker ability to return capital vs. the competitor.
-100.00%
Negative 5Y dividend/share CAGR while PONY stands at 0.00%. Joel Greenblatt sees a weaker commitment to dividends vs. a competitor that might be growing them.
-100.00%
Negative near-term dividend growth while PONY invests at 0.00%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.
84.92%
AR growth well above PONY's 14.29%. Michael Burry fears inflated revenue or higher default risk in the near future.
-0.29%
Inventory is declining while PONY stands at 0.00%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
-10.95%
Negative asset growth while PONY invests at 1.92%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-6.95%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
-36.45%
We’re deleveraging while PONY stands at 38.45%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
-100.00%
Our R&D shrinks while PONY invests at 3.25%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
-22.46%
We cut SG&A while PONY invests at 44.40%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.